Trials / Completed
CompletedNCT02523573
Study of High Flow Nasal Cannula Oxygen for Bronchoscopy With Bronchoalveolar Lavage in ICU Patients
High Flow Nasal Oxygen for Bronchoscopy With Bronchoalveolar Lavage in Acute Respiratory Failure Patients: the OptiBAL Study.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Hôpital Louis Mourier · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Bronchoscopy with bronchoalveolar lavage (BAL) is at risk for worsening hypoxemia in patients with acute respiratory failure (ARF). High-flow nasal cannula oxygen (HFNC) improves hypoxemia in ARF patients . We investigated its efficacy and tolerance in intensive care unit patients admitted for ARF requiring BAL.
Detailed description
Prospective, observational, multicenter study in ARF patients (minimal pulse oximetry -SpO2- of 92% with an minimal oxygen flow of 6 L/min , respiratory rate \> 25/min (20/min if use of accessory respiratory muscles) with a compatible etiology. Primary outcome measure is increase in ventilatory support (non-invasive positive pressure ventilation (NPPV) or endotracheal intubation (ETI)) within the first 24h following BAL.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Adult ARF ICU patients needing BAL with HFNC | bronchoalveolar lavage is performed in spontaneously breathing patients under high flow nasal cannula oxygen |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2015-08-14
- Last updated
- 2016-02-26
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02523573. Inclusion in this directory is not an endorsement.